A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study | Zendy

Holger Reinecke | Zendy; Christiane Engelbertz | Zendy; Rupert Bauersachs | Zendy; Günter Breithardt | Zendy; Hans-Herbert Echterhoff | Zendy; Joachim Gerß | Zendy; Karl Georg Hæusler | Zendy; Bernd Hewing | Zendy; Joachim Hoyer | Zendy; Sabine Juergensmeyer | Zendy; Thomas Klingenheben | Zendy; Guido Knapp | Zendy; Lars Christian Rump | Zendy; Hans Schmidt-Guertler | Zendy; Christoph Wanner | Zendy; Paulus Kirchhof | Zendy; Dennis Göerlich | Zendy

Open Access

A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study

Author(s) -

Holger Reinecke,

Christiane Engelbertz,

Rupert Bauersachs,

Günter Breithardt,

Hans-Herbert Echterhoff,

Joachim Gerß,

Karl Georg Hæusler,

Bernd Hewing,

Joachim Hoyer,

Sabine Juergensmeyer,

Thomas Klingenheben,

Guido Knapp,

Lars Christian Rump,

Hans Schmidt-Guertler,

Christoph Wanner,

Paulus Kirchhof,

Dennis Göerlich

Publication year - 2022

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.122.062779

Subject(s) - medicine , apixaban , vitamin k antagonist , atrial fibrillation , stroke (engine) , hemodialysis , randomized controlled trial , rivaroxaban , cardiology , phenprocoumon , heart failure , kidney disease , surgery , warfarin , mechanical engineering , engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research